Brief twice-weekly episodes of hypoglycemia reduce detection of clinical hypoglycemia in 1 diabetes mellitus

Diabetes

Volumn 47, Issue 9, 1998, Pages 1472-1479

  Ovalle, Fernando ^a   Fanelli, Carmine G ^a   Paramore, Deanna S ^a   Hershey, Tamara ^a   Craft, Suzanne ^a   Cryer, Philip E ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCAGON BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN METABOLISM; MALE; PRIORITY JOURNAL;

EID: 0031679648     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.47.9.1472     Document Type: Article

References (33)

1. Cryer PE: Hypoglycemia in diabetes mellitus. In Hypoglycemia: Pathophysiology, Diagnosis and Treatment. New York/Oxford, Oxford University Press, 1997, p. 91-125
2. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of longterm complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
3. Dagogo-Jack SE, Craft S, Cryer PE: Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. J Clin Invest 91:819-828, 1993
4. Rattarasarn C, Dagogo-Jack SE, Zachwieja JJ, Cryer PE: Hypoglycemiainduced autonomic failure in T1DM is specific for die stimulus of hypoglycemia and is not attributable to prior autonomie activation per se. Diabetes 43:809-818, 1994
5. Fanelli CG, Epifano L, Rambotti AM, Pampanelli S, Di Vincenzo A, Modarelli F, Lepore M, Annibale B, Ciofetta M, Bottini P, Porcellati F, Santeusanio F, Brunetti P, Bolli GB: Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM. Diabetes 42:1683-1689, 1993
6. Cranston I, Lomas J, Maran A, Macdonald I, Amiel SA: Restoration of hypoglycemia unawareness in patients with long duration insulin dependent diabetes mellitus. Lancet 344:283-287, 1994
7. Dagogo-Jack SE, Rattarasarn C, Cryer PE: Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM. Diabetes 43:1426-1434, 1994
8. Fanelli C, Pampanelli S, Epifano L, Rambotti AM, Di Vincenzo A, Modarelli F, Ciofetta M, Lepore M, Annibale B, Torlone E, Perriello G, De Feo P, Santeusanio F, Brunetti P, Bolli GB: Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycemia following institution of rational intensive therapy in IDDM. Diabetotogia - 37:1265-1276, 1994
9. Schwartz NS, Clutter WE, Shah SD, Cryer PE: Glycemie thresholds for acti. vation of glucose counterregulatory systems are higher than the threshold for symptoms. J Clin Invest 79:777-781, 1987
10. Shah S, Clutter W, Cryer PE: External and internal standards in the single isotope derivative (radioenzymatic) assay of plasma norepinephrine and epinephrine in normal humans and patients with diabetes mellitus and chronic renal failure. J Lab Clin Med 106:624-629, 1985
11. Gingerich R, Lacy P, Chance R, Johnson M: Regional pancreatic concentration and in vivo secretion of canine pancreatic polypeptide, insulin and glucagon. Diabetes 27:96-101, 1978
12. Kuzuya H, Blix P, Horwitz D, Steiner D, Rubenstein A: Determination of free and total insulin and C-peptide in insulin treated diabetics. Diabetes 26:22-29, 1977
13. Ensinck J: Immunoassays for glucagon. In Glucagon: Handbook of Experimental Pharmacology. P Lefebrve, Ed. New York, Springer-Verlag, 1983, p. 203-221
14. Schalch D, Parker M: A sensitive double antibody radioimmunoassay for growth hormone in plasma. Nature 703:1141-1142, 1964
15. Farmer R, Pierce C: Plasma cortisol determination: radioimmunoassay and competitive binding compared. Clin Chem 20:411-414, 1974
16. Hosaka K, Kikuchi T, Mitsuhida N, Kawaguchi N: A new colorimetric method for the determination of free fatty acids with acyl-CoA synthetase and acyl CoA oxidase. J Biochem 89:1799-1803, 1981
17. Lowry O, Passoneau J, Hasselberger F, Schultz D; Effect of ischemia on known substrates and co-factors of the glycolytic pathway of the brain. J Biol Chem 239:18-30, 1964
18. Pinter J, Hayaski J, Watson J: Enzymatic assay of glycerol, dihydroxyacetone and glyceraldehyde. Arch Biochem. Biophys 121:404-414, 1967
19. Cahill G, Herrera M, Morgan A, Soeldner J, Steinke J, Levy P, Reichard G, Kipnis D: Hormone-fuel interrelationships during fasting. J Clin Invest 45:1751-1769, 1966
20. 1c. Clin Chem 43:511-517, 1997
21. Towler DA, Havlin CE, Craft S, Cryer PE; Mechanisms of awareness of hypoglycemia: perception of neurogenic (predominantly cholinergic) rather than neuroglycopenic symptoms. Diabetes 42:1791-1798, 1993
22. Hvidberg A, Fanelli CG, Hershey T, Terkamp C, Craft S, Cryer PE: Impact of recent antecedent hypoglycemia on hypoglycemic cognitive dysfunction in nondiabetic humans. Diabetes 45:1030-1036, 1996
23. Lezak MD: Neuropsychological Assessment. New York/Oxford, Oxford University Press, 1995, p. 154-156
24. White NH, Skor DA, Cryer PE, Bier DM, Levandoski L, Santiago JV: Identification of type 1 diabetic patients at increased risk for hypoglycemia during intensive therapy. N Engl J Med 308:485-491, 1983
25. Bolli GB, De Feo P, De Cosmo S, Perriello G, Ventura MM, Massi-Benedetti M, Santeusanio F, Gerich JE, Brunetti P: A reliable and reproducible test for adequate glucose counterregulation in type I diabetes meillitus. Diabetes 33:732-737, 1984
26. Gold AE, MacLeod KM, Frier BM: Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia Diabetes Care 17:697-703, 1994
27. Fanelli CG, Pampanelli S, Porcellati F, Bolli GB: Shift of glycaemic thresholds for cognitive function in hypoglycaemia unawareness in humans. Diabetologia. In press
28. Veneman T, Mitrakou A, Mokan M, Cryer P, Gerich J: Induction of hypoglycemia unawareness by asymptomatic nocturnal hypoglycemia. Diabetes 42:1233-1237, 1993
29. Fanelli C, Paramore D, Hershey T, Terkamp C, Craft S, Cryer P: Impact of nocturnal hypoglycemia on hypoglycemic cognitive dysfunction in type 1 diabetes mellitus (Abstract). Diabetes (Suppl.1) 47: A108, 1998
30. Fanelli C, Pampanelli S, Ciofetta M, Lalli C, Del Sindaco P, Lepore M, Brunetti P, Bolli G: Effect of duration of recent, antecedent hypoglycemia in humans (Abstract). Diabetes 46-41A, 1997
31. Blackman JD, Towle VL, Sturis J, Lewis GF, Spire J-P, Polonsky KS: Hypoglycemie thresholds for cognitive dysfunction in IDDM. Diabetes 41:392-399, 1992
32. Widom B, Simonson DC : Glycemic control and neuropsychologic function during hypoglycemia in patients with insulin-dependent diabetes meilitus. Ann Intern Med 112:904-912, 1990
33. Maran A, Lomas J, Macdonald IA, Amiel SA Lack of protection of higher brain function during hypoglycaemia in patients with intensively treated IDDM. Diabetologia 38:1412-1418, 1995